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1. Introduction
  Inflammation is a reaction of living tissues towards injury, 
it comprises systemic response and local responses[1]. The 
ocean and sea occupies nearly 70% of the world. The marine 
flora and fauna are rich sources of biologically active 
compounds. A large number of toxic metabolites have 
been isolated and characterized from protozoan, sponge, 
coelenterate, echinoderms, mollusks, sea snakes and fishes. 
The great interest in these chemically varied compounds 
has resulted in the development of novel therapeutic 
agents for the treatment of various diseases afflicted 
by human beings. Marine species studied in the recent 
years have yielded a variety of compounds which possess 
known or novel pharmacological activities in mammels 
and have exhibited antimicrobial, anti-inflammatory and 
antineoplastic property. Thunnus alalaunga of the family 
Scrombidae comes under the order Perciformes and class 
Actinopterygii was commonly known as Albacore tuna. It 
lives in the tropical and subtropical region with medium 
resilience, of minimum population with a doubling time 
of 1.4-4.4 yrs. The fish folk community of Southern part of 
India was using the steamed and baked intestine of this 
fish for the treatment of severe back and neck pains. The 
present study aims to authentify that traditional information 
by both in vitro and in vivo anti-inflammatory screening.
2. Materials and methods
2.1. Preparation of extracts
  Fresh tuna was collected from Ponnani of Malappuram 
district Kerala and was authenticated by fisheries experts. 
The glands of fish was separated and ground to a coarse 
form. It was then washed thoroughly with distilled water 
and dried carefully with the help of filter paper. Then it was 
extracted with a mixture of chloroform and water using a 
rotary shaker. The extract was concentrated under reduced 
pressure and preserved at low temperature.
2.2. Chemicals and instruments
  All chemicals used in the estimation were of analytical 
grade. Carrageenan was purchased from sigma chemicals. 
Reference standard diclofenac sodium was obtained as gift 
sample from MRL labs Chennai. Shimadzu 1701 UV Visible 
spectrophotometer was used for the in vitro study.
2.3. Animals
  Adult Wister albino rats (60-120 g) of either sex were 
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used for the in vivo evaluation. They were housed under 
standard laboratory conditions and were fed with standard 
animal feed and water ad libitum. The experimental protocol 
was approved by institutional animal ethical committee.
2.4. Acute toxicity test
  Acute toxicity study was performed as per Organization of 
Economic Cooperation and Development  guidelines 423[2]. 
(Acute toxicity class method).
2.5. Anti-inflammatory activity (in vitro)
  Human red blood cell membrane stabilisation method 
(HRBC method)[3] was used for the estimation of anti-
inflammatory activity in vitro. Blood was collected from 
healthy volunteers and it was mixed with equal volume 
of sterilized Alsevers solution. This blood solution was 
centrifuged at 3 000 rpm and the packed cells were 
separated. The packed cells were washed with isosaline 
solution and a 10% v/v suspension was made with isosaline. 
This HRBC suspension was used for the estimation of anti 
inflammatory property. Different concentrations of extract, 
reference sample and control were separately mixed 
with 1 mL of phosphate buffer, 2 mL of hyposaline and 
0.5 mL of HRBC suspension. All the assay mixtures were 
incubated at 37 曟 for 30 min and centrifuged at 3 000 rpm. 
The supernatant liquid was decanted and the hemoglobin 
content was estimated by a spectrophotometer at 560 nm. 
The percentage hemolysis was estimated by assuming the 
hemolysis produced in the control as 100%.
Percentage protection= [1- (OD sample/ OD control)] 伊 100%
2.6. Anti-inflammatory activity (in vivo)
  Paw oedema was induced on each rat by injecting 0.1 mL of 
carrageenan on physiological saline to the left hind paw. The 
extracts at different concentrations were administered orally 
30 min prior to Carrageenan administration[4]. Paw volumes 
were measured at 60 min, 120 min, 180 min and 240 min 
by mercury displacement method using plethysmograph. 
The percentage inhibition of paw volume in extract treated 
groups was compared with control. Diclofenac sodium  (5 
mg/kg) was used as the standard.
2.7. Statistical analysis
  Statistical analysis was done using one way analysis of 
variance followed by Dunnets t test. P values < 0.05 were 
considered significantly.
3. Results
3.1. Acute toxicity studies
  The extracts of Thunnus alalunga did not cause any sign 
of toxicity up to 2 000 mg/kg body weight and hence it was 
considered to be safe.
3.2. Anti-inflammatory activity (in vitro)
  Thunnus alalunga glandular extracts at different 
concentrations (100 mg/mL, 200 mg/mL, 300 mg/mL, 400 
mg/mL) showed significant stabilization towards HRBC 
membranes. The percentage protection at concentration 300 
mg/mL is more when compared to the other concentrations. 
However on higher concentration the percentage protection 
was found to be decreased.  The results were tabulated in 
Table 1.
3.3. Anti- inflammatory activity (in vivo)
  The extracts of  Thunnus alalunga at dif ferent 
concentrations showed significant reduction in the paw 
volume of rats. The extract at concentration of 400 mg/
mL showed potent activity, comparing with the reference 
standard Diclofenac sodium. The results were tabulated in 
Table 2.
4. Discussion
  Inflammation is common phenomenon and it is a reaction 
of living tissues towards injury. Steroidal anti-inflammatory 
agents will lyse and possibly induce the redistribution 
of lymphocytes causing rapid and transient decrease in 
peripheral blood lymphocyte counts to effect longer term 
response. Thunnus alalunga of the family Scrombidae was 
a common edible fish of Kerala coast and it is popularly 
known as tuna. Chemical evaluation of the glandular extract 
of Thunnus alalunga reveals the presence of steroids. Here 
anti-inflammatory activity was performed based on the 
folk lore information using two methods. HRBC method was 
selected for the in vitro evaluation of anti-inflammatory 
property because the erythrocyte membrane is analogous 
to the lysosomal membrane[5] and its stabilization implies 
that the extract may as well stabilize lysosomal membranes. 
Stabilization of lysosomal membrane is important in 
limiting the inflammatory response by preventing the 
release of lysosomal constituents of activated neutrophil 
such as bactericidal enzymes and proteases, which cause 
further tissue inflammation and damage upon extra 
cellular release. The result indicted that the glandular 
extract of Thunnus alalunga at various concentrations 
had significant anti-inflammatory property. Carrageenan 
induced inflammation is a useful model for the estimation 
Table 1 
In vitro anti-inflammatory activity of glandular extracts of Thunnus 







Diclofenac sodium 5  32.55
 Percentage protection is the mean triplicate readings.
A.K. Azeem et al./Asian Pacific Journal of Tropical Medicine (2010)794-796796
anti inflammatory effect. The development of oedima in the 
paw of the rat after the injection of Carrageenan is due to 
the release of histamine, serotonin and prostaglandin like 
substances[6-8]. Glandular extract of Thunnus alalunga 
showed significant anti inflamatory activity. This significant 
anti-inflammatory effect may be due to the inhibition of 
any inflammatory mediators by the steroids[9] present in 
the extract. The present result indicates the efficacy of 
Thunnus alalunga as an effective therapeutic agent in the 
treatment of acute inflammatory conditions. The result 
of present study authentifies the folk lore information on 
the anti-inflammatory property of the glandular extract of 
Thunnus alalunga. Further detailed study is in process 
for the isolation of active constituent responsible for this 
property and to idendify the possible mechanism of its anti 
inflamattory property.
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Table 2  
Anti-inflammatory activity by Carrageenan induced oedema (mean依SEM)(%) (n=6)
Drug Dose (mg/kg)
Carrageenan induced oedema (Volume in mL)
60 min 120 min 180 min 240 min
Control       0.370依0.020       0.390依0.010       0.430依0.020       0.430依0.010
Diclofenac               5       0.170依0.010(59.3) *       0.160依0.020(65.4) *       0.140依0.004*(66.7)       0.110依0.010*(77.05)
Extract 100       0.280依0.003(32.5) *       0.160依0.020(34.7) *       0.200依0.010*(51.3)       0.180依0.004*(55.8)
Extract 200       0.230依0.004(43.3) *       0.240依0.010(49.6) *       0.190依0.020*(53.7)       0.140依0.007*(64.8)
Extract 300       0.270依0.009(48.5) *       0.230依0.010(49.1) *       0.260依0.020*(65.5)       0.240依0.020*(68.2)
Extract 400       0.160依0.010(57.4) *       0.250依0.004(65.9) *       0.130依0.020*(67.7)       0.110依0.009*(78.6)
*P<0.001 with control. 
